Cargando…

Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis

BACKGROUND: Liver transplantation (LT) is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for LT according to the model for end-stage liver disease-sodium (MELD-Na) score, which may not accurately reflect the burden of living with P...

Descripción completa

Detalles Bibliográficos
Autores principales: Onofrio, Fernanda, Zheng, Katina, Xu, Cherry, Chen, Shiyi, Xu, Wei, Vyas, Mary, Bingham, Katie, Patel, Keyur, Lilly, Leslie, Cattral, Mark, Selzner, Nazia, Jaeckel, Elmar, Tsien, Cynthia, Gulamhusein, Aliya, Hirschfield, Gideon M., Bhat, Mamatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552969/
https://www.ncbi.nlm.nih.gov/pubmed/37534935
http://dx.doi.org/10.1097/HC9.0000000000000219
_version_ 1785116065304412160
author Onofrio, Fernanda
Zheng, Katina
Xu, Cherry
Chen, Shiyi
Xu, Wei
Vyas, Mary
Bingham, Katie
Patel, Keyur
Lilly, Leslie
Cattral, Mark
Selzner, Nazia
Jaeckel, Elmar
Tsien, Cynthia
Gulamhusein, Aliya
Hirschfield, Gideon M.
Bhat, Mamatha
author_facet Onofrio, Fernanda
Zheng, Katina
Xu, Cherry
Chen, Shiyi
Xu, Wei
Vyas, Mary
Bingham, Katie
Patel, Keyur
Lilly, Leslie
Cattral, Mark
Selzner, Nazia
Jaeckel, Elmar
Tsien, Cynthia
Gulamhusein, Aliya
Hirschfield, Gideon M.
Bhat, Mamatha
author_sort Onofrio, Fernanda
collection PubMed
description BACKGROUND: Liver transplantation (LT) is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for LT according to the model for end-stage liver disease-sodium (MELD-Na) score, which may not accurately reflect the burden of living with PSC. We sought to describe and analyze the clinical trajectory for patients with PSC referred for LT, in a mixed deceased donor/living donor transplant program. METHODS: This was a retrospective cohort study from November 2012 to December 2019, including all patients with PSC referred for assessment at the University Health Network Liver Transplant Clinic. Patients who required multiorgan transplant or retransplantation were excluded. Liver symptoms, hepatobiliary malignancy, MELD-Na progression, and death were abstracted from chart review. Competing risk analysis was used for timing of LT, transplant type, and death. RESULTS: Of 172 PSC patients assessed, 84% (n = 144) were listed of whom 74% were transplanted. Mean age was 47.6 years, and 66% were male. Overall mortality was 18.2% at 2 years. During the follow-up, 16% (n = 23) were removed from the waitlist for infection, clinical deterioration, liver-related mortality or new cancer; 3 had clinical improvement. At listing, 82% (n = 118) had a potential living donor (pLD). Patients with pLD had significantly lower waitlist and liver-related waitlist mortality (HR 0.20, p<0.001 and HR 0.17, p<0.001, respectively), and higher rates of transplantation (HR 1.83, p = 0.05). Exception points were granted to 13/172 (7.5%) patients. CONCLUSIONS: In a high-volume North American LT center, most patients with PSC assessed for transplant were listed and subsequently transplanted. However, this was a consequence of patients engaging in living donor transplantation. Our findings support the concern from patients with PSC that MELD-Na allocation does not adequately address their needs.
format Online
Article
Text
id pubmed-10552969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105529692023-10-06 Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis Onofrio, Fernanda Zheng, Katina Xu, Cherry Chen, Shiyi Xu, Wei Vyas, Mary Bingham, Katie Patel, Keyur Lilly, Leslie Cattral, Mark Selzner, Nazia Jaeckel, Elmar Tsien, Cynthia Gulamhusein, Aliya Hirschfield, Gideon M. Bhat, Mamatha Hepatol Commun Original Article BACKGROUND: Liver transplantation (LT) is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for LT according to the model for end-stage liver disease-sodium (MELD-Na) score, which may not accurately reflect the burden of living with PSC. We sought to describe and analyze the clinical trajectory for patients with PSC referred for LT, in a mixed deceased donor/living donor transplant program. METHODS: This was a retrospective cohort study from November 2012 to December 2019, including all patients with PSC referred for assessment at the University Health Network Liver Transplant Clinic. Patients who required multiorgan transplant or retransplantation were excluded. Liver symptoms, hepatobiliary malignancy, MELD-Na progression, and death were abstracted from chart review. Competing risk analysis was used for timing of LT, transplant type, and death. RESULTS: Of 172 PSC patients assessed, 84% (n = 144) were listed of whom 74% were transplanted. Mean age was 47.6 years, and 66% were male. Overall mortality was 18.2% at 2 years. During the follow-up, 16% (n = 23) were removed from the waitlist for infection, clinical deterioration, liver-related mortality or new cancer; 3 had clinical improvement. At listing, 82% (n = 118) had a potential living donor (pLD). Patients with pLD had significantly lower waitlist and liver-related waitlist mortality (HR 0.20, p<0.001 and HR 0.17, p<0.001, respectively), and higher rates of transplantation (HR 1.83, p = 0.05). Exception points were granted to 13/172 (7.5%) patients. CONCLUSIONS: In a high-volume North American LT center, most patients with PSC assessed for transplant were listed and subsequently transplanted. However, this was a consequence of patients engaging in living donor transplantation. Our findings support the concern from patients with PSC that MELD-Na allocation does not adequately address their needs. Lippincott Williams & Wilkins 2023-08-03 /pmc/articles/PMC10552969/ /pubmed/37534935 http://dx.doi.org/10.1097/HC9.0000000000000219 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Onofrio, Fernanda
Zheng, Katina
Xu, Cherry
Chen, Shiyi
Xu, Wei
Vyas, Mary
Bingham, Katie
Patel, Keyur
Lilly, Leslie
Cattral, Mark
Selzner, Nazia
Jaeckel, Elmar
Tsien, Cynthia
Gulamhusein, Aliya
Hirschfield, Gideon M.
Bhat, Mamatha
Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title_full Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title_fullStr Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title_full_unstemmed Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title_short Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
title_sort living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552969/
https://www.ncbi.nlm.nih.gov/pubmed/37534935
http://dx.doi.org/10.1097/HC9.0000000000000219
work_keys_str_mv AT onofriofernanda livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT zhengkatina livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT xucherry livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT chenshiyi livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT xuwei livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT vyasmary livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT binghamkatie livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT patelkeyur livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT lillyleslie livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT cattralmark livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT selznernazia livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT jaeckelelmar livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT tsiencynthia livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT gulamhuseinaliya livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT hirschfieldgideonm livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis
AT bhatmamatha livingdonorlivertransplantationcanaddressdisparitiesintransplantaccessforpatientswithprimarysclerosingcholangitis